Prognostic Factors in Primary Central Nervous System Lymphomas
- 3 August 2005
- journal article
- review article
- Published by Elsevier in Hematology/Oncology Clinics of North America
- Vol. 19 (4) , 629-649
Abstract
No abstract availableKeywords
This publication has 61 references indexed in Scilit:
- Primary Central Nervous System Lymphoma: Results of a Pilot and Phase II Study of Systemic and Intraventricular Chemotherapy With Deferred RadiotherapyJournal of Clinical Oncology, 2003
- Prognostic Scoring System for Primary CNS Lymphomas: The International Extranodal Lymphoma Study Group ExperienceJournal of Clinical Oncology, 2003
- Combination Chemotherapy and Radiotherapy for Primary Central Nervous System Lymphoma: Radiation Therapy Oncology Group Study 93-10Journal of Clinical Oncology, 2002
- Treatment for Primary CNS Lymphoma: The Next StepJournal of Clinical Oncology, 2000
- Phase II Multicenter Study of Brief Single-Agent Methotrexate Followed by Irradiation in Primary CNS LymphomaJournal of Clinical Oncology, 2000
- Radiotherapy in the Treatment of Primary Central Nervous System Lymphoma (PCNSL)Journal of Neuro-Oncology, 1999
- Primary central nervous system lymphoma in japan: a nationwide surveyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1999
- Primary central nervous system lymphoma: age and performance status are more important than treatment modalityInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1998
- Primary central nervous system lymphoma: analysis of prognostic variables and patterns of treatment failure.Radiology, 1990
- Prognostic factors in the diagnosis and treatment of primary central nervous system lymphomaCancer, 1989